Neuroanesthesia & neurocritical care

Association of Early Dexmedetomidine Utilization With Clinical Outcomes After Moderate-Severe Traumatic Brain Injury: A Retrospective Cohort Study

Anesth AnalgPublished Retrospective cohort study

Main findingResult — go to the resultOdds ratio 0.59 95% CI 0.47–0.74

Authors' conclusion

Dexmedetomidine is being utilized increasingly as a sedative for mechanically ventilated patients with msTBI. Early dexmedetomidine exposure may lead to improved patient outcomes in this population.

Study context

Population
Critically ill adults with moderate-severe traumatic brain injury (TBI) (head-neck abbreviated injury scale (AIS) 3–5) requiring mechanical ventilation, US, January 2016 to June 2020required mechanical ventilation (MV) within 2 days of ICU admission
Participants
19,751 adults
Exposure
Early dexmedetomidine exposure vs no early exposure
Outcome
Hospital mortality
Methodological detailspropensity-score matched, Premier dataset
  • Propensity-score matched
  • Premier dataset

Main finding

As reported in the abstract

Odds ratio

0.59

95% CI 0.47–0.74

P < 0.0001

Early dexmedetomidine vs No early dexmedetomidine
OR 0.59 (95% CI 0.47–0.74); P < 0.0001

Observational data: associations, not effects.

Secondary outcomes

OutcomeEstimateP value
Liberation from MVHR 1.20 (95% CI 1.09–1.33)P = 0.0003
Hospital LOSReduced LOSHR 1.11 (95% CI 1.01–1.22)P = 0.033
Hemodialysis after the first 2 daysOR 1.14 (95% CI 0.73–1.78)P = 0.56
Vasopressor use after the first 2 daysOR 1.10 (95% CI 0.78–1.55)P = 0.60
OutcomeRelative cost ratio (95% CI)P value
Hospital costsEstimate as printed lies outside its CI1.98 (0.93–1.03)P = 0.66

Annual dexmedetomidine utilization, 2016 to 2020

Annual percent utilization of dexmedetomidine increased from 4.05% to 8.60%

Original publication

Association of Early Dexmedetomidine Utilization With Clinical Outcomes After Moderate-Severe Traumatic Brain Injury: A Retrospective Cohort Study. Anesth Analg. Published 15 July 2024. doi:10.1213/ane.0000000000006869

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.